Artificial Intelligence Debate in Medicare Patient Supply Processes
Democratic lawmakers criticized a federal pilot program that uses artificial intelligence to review Medicare patient health claims, stating that it has led to widespread delays and denials.
American doctors and Democratic lawmakers gathered to discuss a new federal pilot program implemented in six states. It was stated that under the program, private companies use artificial intelligence to approve Medicare patient procedures, which has caused delays and denials in care processes.
Scope and Operation of the Pilot Program
The pilot program, which went into effect on January 1 and is planned to last for six years, covers Medicare patient healthcare services in six states, including Washington.
The model involves private companies reviewing prior authorization requests for 17 different procedures and utilizing artificial intelligence technology in this process.
AI-Powered Denial Decisions
A company named Virtix Health, which manages the process in Washington state, denied more requests than it approved in the first three months of 2026.
Treatments reviewed by the artificial intelligence tool include nerve stimulation, cervical fusion surgery, and treatments for chronic pain or incontinence.
Reactions from Doctors and Senators
Doctors attending the meeting stated that the artificial intelligence tool routinely denies prior authorization requests for the 17 procedures in its scope, and appealing the decisions can take months.
Washington Democratic Senator Patty Murray is working to terminate the pilot program and opposes this practice.